Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers

B Delcoigne; L Ljung; SA Provan; Bente Glintborg; Kathrine Lederballe Grøn; Merete Lund Hetland; NS Krogh; N Trokovic; H Relas; C Turesson; B Michelsen

Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers

B Delcoigne, L Ljung, SA Provan, Bente Glintborg, Kathrine Lederballe Grøn, Merete Lund Hetland, NS Krogh, N Trokovic, H Relas, C Turesson, B Michelsen

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Artikelnummer	OP0114
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	80
Udgave nummer	Supplement 1
Sider (fra-til)	63-4
Antal sider	2
ISSN	0003-4967
Status	Udgivet - 2021

Citationsformater

Delcoigne, B., Ljung, L., Provan, SA., Glintborg, B., Grøn, K. L., Hetland, M. L., Krogh, NS., Trokovic, N., Relas, H., Turesson, C., & Michelsen, B. (2021). Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers. Annals of the Rheumatic Diseases, 80(Supplement 1), 63-4. [OP0114].

Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers. / Delcoigne, B; Ljung, L; Provan, SA et al.

I: Annals of the Rheumatic Diseases, Bind 80, Nr. Supplement 1, OP0114, 2021, s. 63-4.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Delcoigne, B, Ljung, L, Provan, SA, Glintborg, B , Grøn, KL , Hetland, ML, Krogh, NS, Trokovic, N, Relas, H, Turesson, C & Michelsen, B 2021, 'Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers', Annals of the Rheumatic Diseases, bind 80, nr. Supplement 1, OP0114, s. 63-4.

Delcoigne B, Ljung L, Provan SA, Glintborg B , Grøn KL , Hetland ML et al. Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers. Annals of the Rheumatic Diseases. 2021;80(Supplement 1):63-4. OP0114.

Delcoigne, B ; Ljung, L ; Provan, SA et al. / Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers. I: Annals of the Rheumatic Diseases. 2021 ; Bind 80, Nr. Supplement 1. s. 63-4.

@article{f37dd9a1f0214e5bbdbe39d0c155e82e,

title = "Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers",

author = "B Delcoigne and L Ljung and SA Provan and Bente Glintborg and Gr{\o}n, {Kathrine Lederballe} and Hetland, {Merete Lund} and NS Krogh and N Trokovic and H Relas and C Turesson and B Michelsen",

note = "COPECARE",

year = "2021",

language = "English",

volume = "80",

pages = "63--4",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Supplement 1",

}

TY - ABST

T1 - Short- and longer-term risks for acute coronary syndrome in patients with rheumatoid arthritis starting treatment with disease-modifying anti-rheumatic drugs. A collaborative observational head-to-head study across five Nordic rheumatology registers

AU - Delcoigne, B

AU - Ljung, L

AU - Provan, SA

AU - Glintborg, Bente

AU - Grøn, Kathrine Lederballe

AU - Hetland, Merete Lund

AU - Krogh, NS

AU - Trokovic, N

AU - Relas, H

AU - Turesson, C

AU - Michelsen, B

N1 - COPECARE

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

VL - 80

SP - 63

EP - 64

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Supplement 1

M1 - OP0114

ER -